Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023

Rhea-AI Summary

Agile Therapeutics, Inc. will report its third quarter 2023 financial results on November 9, 2023. A live conference call and webcast will be held at 8:30 a.m. ET to discuss the results and provide a business update.

Positive

• Agile Therapeutics will report its third quarter financial results, which could positively impact the stock price if the results exceed expectations.

Negative

• No negative takes found.

Live Conference Call and Webcast at 8:30 a.m. ET

PRINCETON, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report third quarter 2023 financial results before the market open on Thursday, November 9, 2023. Following the release, the Company will host a live conference call and webcast at 8:30 a.m. ET to discuss the Company’s financial results and provide a business update.

Event	Agile Therapeutics Third Quarter 2023 Financial Results Conference Call
Date	Thursday, November 9, 2023
Time	8:30 a.m. ET / 5:30 a.m. PT

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

About Agile Therapeutics, Inc.

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website, Twitter account (@agilether), and LinkedIn account.

Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

FAQ

When will Agile Therapeutics report its third quarter 2023 financial results?

Agile Therapeutics will report its third quarter 2023 financial results on November 9, 2023.

What will be discussed during the live conference call and webcast?

During the live conference call and webcast, Agile Therapeutics will discuss its financial results and provide a business update.

How can I access the live webcast of the conference call?

The live webcast of the conference call can be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations.

How can I participate in the live conference call via telephone?

To participate in the live conference call via telephone, you can register on the provided link. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.